Bucking the trend of IL-12 therapy program failures, Imunon’s IMNN-001 was bolstered by positive translational data in ovarian cancer.

Bispecific antibodies can be manufactured in bulk, stored, and delivered like traditional antibody drugs. This means they ...

Their recent efforts have involved optimizing the therapy and expanding its uses to other cancers and diseases. The Inquirer ...

A tragic RSV vaccine trial in the 1960s set the field back for decades. Here’s how scientists finally made breakthroughs in ...

Mental health: Lupus causes issues with mental health and thinking, due to a cognitive impairment commonly known as “brain ...

Commit to Healthier Eating: Foods like fruits, vegetables, nuts, seeds, legumes and whole grains are recommended by experts ...

An engineering playbook for creating disease-resistant crops is finally here.

For more than 40 years, doctors have noticed a strange medical mystery: people who smoke are less likely to suffer from ...

Results from OVATION 2 Study reinforce IMNN-001 efficacy benefits observed in the clinic and unique mechanism of action, producing key anti-cancer immune cytokines post-treatment ...

Scientists have discovered that cancer uses a hidden hormone to switch off the body’s natural defenses, allowing tumors to ...

AK130 is the world’s first and only TIGIT/TGF-β bifunctional antibody fusion protein in registrational clinical development. The initiation of the AK130-202 study marks a significant milestone in ...

AI tool bridges the gap between doctor and patient and helps decode and simplify some of the post-therapy instructions for ...